Cefiderocol versus imipenem-cilastatin for the treatment of complicated urinary tract infections caused by gram-negative uropathogens: a phase 2, randomised, double-blind, non-inferiority trial - Portsmouth, S; van Veenhuyzen, D; Echols, R (Lancet Infect Dis, 2018)
, et al.